These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 22764095)
1. Role of c-Myb in the survival of pre B-cell acute lymphoblastic leukemia and leukemogenesis. Sarvaiya PJ; Schwartz JR; Hernandez CP; Rodriguez PC; Vedeckis WV Am J Hematol; 2012 Oct; 87(10):969-76. PubMed ID: 22764095 [TBL] [Abstract][Full Text] [Related]
2. Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia. Linger RM; DeRyckere D; Brandão L; Sawczyn KK; Jacobsen KM; Liang X; Keating AK; Graham DK Blood; 2009 Sep; 114(13):2678-87. PubMed ID: 19643988 [TBL] [Abstract][Full Text] [Related]
3. c-Myb interacts with the glucocorticoid receptor and regulates its level in pre-B-acute lymphoblastic leukemia cells. Sarvaiya PJ; Schwartz JR; Geng CD; Vedeckis WV Mol Cell Endocrinol; 2012 Sep; 361(1-2):124-32. PubMed ID: 22516378 [TBL] [Abstract][Full Text] [Related]
4. Mer receptor tyrosine kinase is a therapeutic target in pre-B-cell acute lymphoblastic leukemia. Linger RM; Lee-Sherick AB; DeRyckere D; Cohen RA; Jacobsen KM; McGranahan A; Brandão LN; Winges A; Sawczyn KK; Liang X; Keating AK; Tan AC; Earp HS; Graham DK Blood; 2013 Aug; 122(9):1599-609. PubMed ID: 23861246 [TBL] [Abstract][Full Text] [Related]
8. c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells. Waldron T; De Dominici M; Soliera AR; Audia A; Iacobucci I; Lonetti A; Martinelli G; Zhang Y; Martinez R; Hyslop T; Bender TP; Calabretta B Leukemia; 2012 Apr; 26(4):644-53. PubMed ID: 21960247 [TBL] [Abstract][Full Text] [Related]
9. BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3. Nakayama J; Yamamoto M; Hayashi K; Satoh H; Bundo K; Kubo M; Goitsuka R; Farrar MA; Kitamura D Blood; 2009 Feb; 113(7):1483-92. PubMed ID: 19047679 [TBL] [Abstract][Full Text] [Related]
10. Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance. Han SS; Han S; Kamberos NL Biochem Biophys Res Commun; 2014 Sep; 452(3):669-75. PubMed ID: 25193702 [TBL] [Abstract][Full Text] [Related]
11. Targeting of the deubiquitinase USP9X attenuates B-cell acute lymphoblastic leukemia cell survival and overcomes glucocorticoid resistance. Zhou M; Wang T; Lai H; Zhao X; Yu Q; Zhou J; Yang Y Biochem Biophys Res Commun; 2015 Apr; 459(2):333-339. PubMed ID: 25735983 [TBL] [Abstract][Full Text] [Related]